PFS and OS of each variable from the subgroups were divided on the basis of the cutoff values
PFS | OS | ||||
Median | P | Median | P | ||
Post-treatment ECOG | 0.0031 | ||||
0-1 point | 9.93 | ||||
2-3 point | 7.26 | ||||
Post-treatment granulocytes/lymphocytes ratio | 0.0008 | < 0.0001 | |||
≤ 3.1 | 5.97 | 11.16 | |||
> 3.1 | 4.45 | 8.18 | |||
Pre-randomization maximal target lesion length (mm) | 0.0002 | ||||
≤ 72 | 10.38 | ||||
> 72 | 7.98 | ||||
Hypertension | < 0.0001 | ||||
Yes | 5.65 | ||||
No | 3.42 | ||||
Hand-foot syndrome | < 0.0001 | ||||
Yes | 6.51 | ||||
No | 3.80 | ||||
Hyperglycemia | 0.0003 | ||||
Yes | 5.60 | ||||
No | 3.93 | ||||
Hypertriglyceridemia | < 0.0001 | < 0.0001 | |||
Yes | 5.67 | 10.23 | |||
No | 3.41 | 7.29 | |||
Elevated thyroid stimulating hormone | < 0.0001 | ||||
Yes | 5.66 | ||||
No | 3.61 | ||||
Elevated alkaline phosphatase | 0.0286 | ||||
Yes | 4.23 | ||||
No | 5.32 |